Roundworm icon overlaid with the text roundworm, a family health risk

Roundworms

A family health risk

Human toxocarosis is an often
forgotten zoonotic disease,
which can cause major health
concerns,
including reduced
cognitive development and
even blindness

A background image
UP TO
70%

of puppies are infested

by Toxocara canis16

A background image
UP TO
30%

of children's public

play areas are contaminated

with T. canis eggs17

A background image
BUT ONLY
34%

of dog owners

treat their pets for

GI worms18

A background image A background image

ESCCAP‡ recommendations for
control of Toxocara canis:

“As the prepatent period
for Toxocara is a little
over four weeks,
monthly
treatment will minimise the
risk of patent infections”3

‡ European Scientific Council Companion
Animal Parasites

Nexgard Spectra minimises family risk

NexGard Spectra virtually
eliminates shedding

of Toxocara19

Arrow style bullet point Minimises environmental
contamination
Arrow style bullet point Reduces the risk for human
infection
Do It Right, Do It Monthly blue circular interruptor and the words Fleas, Ticks, Lungworm, Roundworm around the edge of the circle.
Do It Right, Do It Monthly blue circular interruptor and the words Fleas, Ticks, Lungworm, Roundworm around the edge of the circle.
Boehringer Ingelheim logo

*Worm control guidelines advise that monthly treatment minimises the risk of patent infections with Toxocara spp, and that prevention of angiostrongylosis
can be achieved with monthly administration of macrocyclic lactones (Worm Control in Dogs and Cats, ESCCAP Guideline 01 Third Edition – July 2017).

3. ESCCAP. Worm Control in Dogs and Cats. ESCCAP Guideline 01 Third Edition 2017. p.1–39.
16. Beugnet F. Helminthoses digestives des carnivores domestiques. EMC (Elsevier Masson SAS, Paris), Veterinaire, Gastro-enterologie. 2010;0300:1–31.
17. Kirchheimer R, Jacobs DE. Toxocara species egg contamination of soil from children’s play areas in southern England. Vet Rec 2008;163:394–395.
18. Ipsos. Pet Owner Clarity Report: Towards a holistic understanding of pet owners motivations & needs Report for Merial Europe. 2016.
19. Rehbein S, Knaus M, Mallouk Y, Breiltgens T, Brianti E, Capari B, Dantas-Torres F, Gau M, Joachim A, Kaulfuss KH, Kirkova Z, Lechner J, Mihalca AD, Mirabito R, Petkevicius S, Rapti D, Shukullari E, Sedeilhan M, Dollhofer D,
Kley K, Lebon W, Visser M, Jeannin P. Efficacy against nematode infections and safety of afoxolaner plus milbemycin oxime chewable tablets in domestic dogs under field conditions in Europe. Parasitol Res 2017;116:259–269.

NexGard Spectra contains afoxolaner and milbemycin oxime. UK: POM-V IE: POM. Further information available in the SPC or from Boehringer Ingelheim Animal Health, RG12 8YS, UK.
UK Tel: 01344 746959 (sales) or 01344 746957 (technical), IE Tel: 01 291 3985 (all queries). Email: vetenquiries@boehringer-ingelheim.com. NexGard Spectra is a registered trademark of the Boehringer Ingelheim Group.
©2019 Boehringer Ingelheim Animal Health UK Ltd.
All rights reserved. Date of preparation: October 2019. AHD12868. Use Medicines Responsibly.